Company Data
Trevi Therapeutics Inc.
Ticker
TRVI
Current Price
$4.8 5.03%
Market Cap
$369.0M
Price Target
Refer to Report
Volume
3.6M
52wk Range
$2.3 - $4.68
Overview
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. It is involved in developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, or IPF, and levodopa-induced dyskinesia, or LID, in patients with Parkinson’s disease.